Trials / Unknown
UnknownNCT00139165
Long-Term Treatment of Collagenous Colitis With Budesonide
Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 36 (planned)
- Sponsor
- Bonderup, Ole K., M.D. · Individual
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide | Capsule. Oral 6 mg o.d. for 24 weeks |
| PROCEDURE | sigmoidoscopy | Sigmoidoscopy performed 2 times during the study period. |
Timeline
- Start date
- 2004-09-01
- Completion
- 2006-03-01
- First posted
- 2005-08-31
- Last updated
- 2008-03-06
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00139165. Inclusion in this directory is not an endorsement.